Recursion Pharmaceuticals Stock Probability of Future Stock Price Finishing Under 10.36
| RXRX Stock | USD 7.46 0.81 9.79% |
Recursion |
Recursion Pharmaceuticals Target Price Odds to finish below 10.36
The tendency of Recursion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 10.36 after 90 days |
| 7.46 | 90 days | 10.36 | close to 99 |
Based on a normal probability distribution, the odds of Recursion Pharmaceuticals to stay under $ 10.36 after 90 days from now is close to 99 (This Recursion Pharmaceuticals probability density function shows the probability of Recursion Stock to fall within a particular range of prices over 90 days) . Probability of Recursion Pharmaceuticals price to stay between its current price of $ 7.46 and $ 10.36 at the end of the 90-day period is about 6.44 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.52 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Recursion Pharmaceuticals will likely underperform. Additionally Recursion Pharmaceuticals has an alpha of 0.243, implying that it can generate a 0.24 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Recursion Pharmaceuticals Price Density |
| Price |
Predictive Modules for Recursion Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Recursion Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Recursion Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Recursion Pharmaceuticals is not an exception. The market had few large corrections towards the Recursion Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Recursion Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Recursion Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.24 | |
β | Beta against Dow Jones | 1.52 | |
σ | Overall volatility | 0.52 | |
Ir | Information ratio | 0.06 |
Recursion Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Recursion Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Recursion Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Recursion Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 44.58 M. Net Loss for the year was (328.07 M) with loss before overhead, payroll, taxes, and interest of (164.13 M). | |
| Recursion Pharmaceuticals currently holds about 515.44 M in cash with (287.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. | |
| Roughly 69.0% of the company shares are owned by institutional investors | |
| Latest headline from benzinga.com: Unpacking the Latest Options Trading Trends in Recursion Pharmaceuticals |
Recursion Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Recursion Stock often depends not only on the future outlook of the current and potential Recursion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Recursion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 207.9 M | |
| Cash And Short Term Investments | 391.6 M |
Recursion Pharmaceuticals Technical Analysis
Recursion Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Recursion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Recursion Pharmaceuticals. In general, you should focus on analyzing Recursion Stock price patterns and their correlations with different microeconomic environments and drivers.
Recursion Pharmaceuticals Predictive Forecast Models
Recursion Pharmaceuticals' time-series forecasting models is one of many Recursion Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Recursion Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Recursion Pharmaceuticals
Checking the ongoing alerts about Recursion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Recursion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Recursion Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 44.58 M. Net Loss for the year was (328.07 M) with loss before overhead, payroll, taxes, and interest of (164.13 M). | |
| Recursion Pharmaceuticals currently holds about 515.44 M in cash with (287.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. | |
| Roughly 69.0% of the company shares are owned by institutional investors | |
| Latest headline from benzinga.com: Unpacking the Latest Options Trading Trends in Recursion Pharmaceuticals |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.